Matinas BioPharma's MAT2203 — Encochleated Formulation of Amphotericin B — Shows Potential to Target and Penetrate Tissue Infected With Invasive Candidiasis in Data Presented at ICAAC/ICC 2015

BEDMINSTER, N.J., Sept. 18, 2015 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of...

DigitasLBi Wins Five 2015 CLIO Awards

NEW YORK, Sept. 18, 2015 (GLOBE NEWSWIRE) — DigitasLBi, a global marketing and technology company, today announces that it has won a total of five 2015 CLIO Awards. The company has been recognized for its creative achievements in multiple categories including...